drugset / Trial / NCT00578331

Safety Study of Olopatadine Nasal Spray

NCT00578331

Phase 3 Completed 890 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.

Timeline

Start
2006-12
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified 0.6 % Intranasal